RUA Life Sciences (GB:RUA) has released an update.
RUA Life Sciences, the company behind the leading implantable polymer Elast-Eon™, has secured a significant new contract worth over £400,000 for a short turnaround textile processing project, with potential for a long-term supply agreement. This project reinforces the company’s reputation for high-quality medical device products and showcases the confidence that major medical firms have in RUA’s offerings. The company, known for its medical device business and patented polymer technology, continues to pursue its vision to enhance patient lives through innovative medical devices.
For further insights into GB:RUA stock, check out TipRanks’ Stock Analysis page.
